Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Northwestern University
Headquarters: Evanston, IL, United States of America
Website: http://www.northwestern.edu
Year Founded: 1850
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 7, 2024
Discovery & Translation
Science Spotlight: Multi-epitope antivirals, metastatic transition, and more
BioCentury’s roundup of translational innovations also includes a study from Amgen and a newco spotlight
BioCentury | Aug 2, 2024
Distillery Therapeutics
Increasing hexosamine synthesis for α-synucleinopathies
BioCentury | Feb 10, 2024
Discovery & Translation
Science spotlight: Moonlight’s enhanced T cells; plus a HUNK inhibitor and more
BioCentury’s roundup of translational innovations
BioCentury | Dec 15, 2023
Discovery & Translation
New targets at ASH point to AML combos, continued sickle cell interest
Innovation in protein degradation also on display, while immunotherapy targets are notably absent
BioCentury | Oct 25, 2023
Finance
Oct. 25 Quick Takes: U.K. takes next step in pension fund reforms
Plus: CBC-backed R-Bridge realizes royalty exit, and updates from Akebia, DermBiont, GSK and Flashpoint
BioCentury | Oct 13, 2023
Discovery & Translation
eGenesis’ kidney xenotransplant; plus Epirium, Neurimmune and more
BioCentury’s roundup of translational innovations
BioCentury | Sep 14, 2023
Regulation
FDA to weigh how broadly to expand label for Alnylam’s Onpattro
FDA panel votes 9-3 that the benefits of Onpattro to treat ATTR cardiomyopathy outweigh risks
BioCentury | Sep 12, 2023
Discovery & Translation
Lurie winners show mitochondria is more than a powerhouse
Northwestern’s Navdeep Chandel and Harvard’s Vamsi Mootha share the FNIH’s 2023 prize for pioneering mitochondrial biology beyond ATP
BioCentury | Jul 7, 2023
Discovery & Translation
Smaller gene editors, Resilience’s cell-free antibody discovery platform and more
BioCentury’s roundup of translational innovations
Items per page:
1 - 10 of 274